• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶/尿激酶受体系统介导了免疫球蛋白G免疫复合物诱导的肺部炎症。

The urokinase/urokinase receptor system mediates the IgG immune complex-induced inflammation in lung.

作者信息

Shushakova Nelli, Eden Gabriele, Dangers Marc, Menne Jan, Gueler Faikah, Luft Friedrich C, Haller Hermann, Dumler Inna

机构信息

Department of Nephrology, Medical School Hannover, Hannover, Germany.

出版信息

J Immunol. 2005 Sep 15;175(6):4060-8. doi: 10.4049/jimmunol.175.6.4060.

DOI:10.4049/jimmunol.175.6.4060
PMID:16148155
Abstract

Immune complex (IC) deposition induces an acute inflammatory response with tissue injury. IC-induced inflammation is mediated by inflammatory cell infiltration, a process highly regulated by the cell surface-specific receptor (uPAR), a binding partner for the urokinase-type plasminogen activator (uPA). We assessed the role of the uPA/uPAR system in IC-induced inflammation using the pulmonary reverse passive Arthus reaction in mice lacking uPA and uPAR compared with their corresponding wild-type controls. Both uPA-deficient C57BL/6J (uPA(-/-)) and uPAR-deficient mice on a mixed C57BL/6J (75%) x 129 (25%) background (uPAR(-/-)) demonstrated a marked reduction of the inflammatory response due to decreased production of proinflammatory mediators TNF-alpha and Glu-Leu-Arg (ELR)-CXC chemokine MIP-2. In uPAR(-/-) animals, the reduction of inflammatory response was more pronounced because of decreased migratory capacity of polymorphonuclear leukocytes. We show that the uPA/uPAR system is activated in lung of wild-type mice, particularly in resident alveolar macrophages (AM), early in IC-induced alveolitis. This activation is necessary for an adequate C5a anaphylatoxin receptor signaling on AM that, in turn, modulates the functional balance of the activating/inhibitory IgG FcgammaRs responsible for proinflammatory mediator release. These data provide the first evidence that the uPA/uPAR plays an important immunoregulatory role in the initiation of the reverse passive Arthus reaction in the lung by setting the threshold for C5a anaphylatoxin receptor/FcgammaR activation on AM. The findings indicate an important link between the uPA/uPAR system and the two main components involved in the IC inflammation, namely, complement and FcgammaRs.

摘要

免疫复合物(IC)沉积会引发伴有组织损伤的急性炎症反应。IC诱导的炎症由炎症细胞浸润介导,这一过程受到细胞表面特异性受体(uPAR)的高度调控,uPAR是尿激酶型纤溶酶原激活剂(uPA)的结合伴侣。我们通过在缺乏uPA和uPAR的小鼠中使用肺部反向被动Arthus反应,并与相应的野生型对照进行比较,评估了uPA/uPAR系统在IC诱导的炎症中的作用。在混合的C57BL/6J(75%)×129(25%)背景下的uPA缺陷型C57BL/6J(uPA(-/-))小鼠和uPAR缺陷型小鼠(uPAR(-/-))均显示,由于促炎介质肿瘤坏死因子-α(TNF-α)和谷氨酸-亮氨酸-精氨酸(ELR)-CXC趋化因子MIP-2的产生减少,炎症反应明显减轻。在uPAR(-/-)动物中,由于多形核白细胞的迁移能力降低,炎症反应的减轻更为明显。我们发现,在IC诱导的肺泡炎早期,野生型小鼠的肺中,特别是在驻留肺泡巨噬细胞(AM)中,uPA/uPAR系统被激活。这种激活对于AM上充分的C5a过敏毒素受体信号传导是必要的,而这反过来又调节了负责促炎介质释放的激活/抑制性IgG FcγR的功能平衡。这些数据首次证明,uPA/uPAR通过设定AM上C5a过敏毒素受体/FcγR激活的阈值,在肺部反向被动Arthus反应的启动中发挥重要的免疫调节作用。这些发现表明uPA/uPAR系统与IC炎症中涉及的两个主要成分,即补体和FcγR之间存在重要联系。

相似文献

1
The urokinase/urokinase receptor system mediates the IgG immune complex-induced inflammation in lung.尿激酶/尿激酶受体系统介导了免疫球蛋白G免疫复合物诱导的肺部炎症。
J Immunol. 2005 Sep 15;175(6):4060-8. doi: 10.4049/jimmunol.175.6.4060.
2
A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.神经元型尿激酶型纤溶酶原激活剂(uPA)与星形胶质细胞型uPA受体(uPAR)之间的相互作用促进缺血性脑内星形胶质细胞激活和突触恢复。
J Neurosci. 2017 Oct 25;37(43):10310-10322. doi: 10.1523/JNEUROSCI.1630-17.2017. Epub 2017 Sep 20.
3
Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation.巨噬细胞通过控制C5aR和Fc受体协同作用的Gαi2激活,在肺部阿瑟斯反应中诱导炎症反应。
J Immunol. 2005 Mar 1;174(5):3041-50. doi: 10.4049/jimmunol.174.5.3041.
4
Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro.尿激酶缺陷型和尿激酶受体缺陷型小鼠在体外的中性粒细胞抗菌激活功能受损。
J Leukoc Biol. 2004 Sep;76(3):648-56. doi: 10.1189/jlb.0104023. Epub 2004 Jul 7.
5
Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia.尿激酶受体对于宿主有效抵御肺炎球菌肺炎是必需的。
J Immunol. 2002 Apr 1;168(7):3507-11. doi: 10.4049/jimmunol.168.7.3507.
6
Renal urokinase-type plasminogen activator (uPA) receptor but not uPA deficiency strongly attenuates ischemia reperfusion injury and acute kidney allograft rejection.肾组织中尿激酶型纤溶酶原激活剂(uPA)受体缺乏而非uPA缺乏,可显著减轻缺血再灌注损伤和急性肾移植排斥反应。
J Immunol. 2008 Jul 15;181(2):1179-89. doi: 10.4049/jimmunol.181.2.1179.
7
C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.C5a过敏毒素是免疫复合物诱导的肺部疾病中激活型与抑制型Fcγ受体的主要调节因子。
J Clin Invest. 2002 Dec;110(12):1823-30. doi: 10.1172/JCI16577.
8
Urokinase-induced activation of the gp130/Tyk2/Stat3 pathway mediates a pro-inflammatory effect in human mesangial cells via expression of the anaphylatoxin C5a receptor.尿激酶诱导的gp130/Tyk2/Stat3信号通路激活通过过敏毒素C5a受体的表达介导人系膜细胞中的促炎作用。
J Cell Sci. 2005 Jun 15;118(Pt 12):2743-53. doi: 10.1242/jcs.02409.
9
Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice.尿激酶和尿激酶受体缺陷小鼠中与重症疟疾相关的延迟死亡和血小板减少症减轻
Infect Immun. 2000 Jul;68(7):3822-9. doi: 10.1128/IAI.68.7.3822-3829.2000.
10
Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor.尿激酶型纤溶酶原激活剂可独立于其细胞受体支持肝脏修复。
BMC Gastroenterol. 2006 Nov 29;6:40. doi: 10.1186/1471-230X-6-40.

引用本文的文献

1
Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor.外源性尿激酶抑制其同源尿激酶型纤溶酶原激活物受体的蛋白酶体降解。
Front Pharmacol. 2022 Aug 12;13:754271. doi: 10.3389/fphar.2022.754271. eCollection 2022.
2
TLR4 Response to LPS Is Reinforced by Urokinase Receptor.尿激酶受体增强 TLR4 对 LPS 的反应。
Front Immunol. 2020 Dec 9;11:573550. doi: 10.3389/fimmu.2020.573550. eCollection 2020.
3
Bronchial lesions of mouse model of asthma are preceded by immune complex vasculitis and induced bronchial associated lymphoid tissue (iBALT).
哮喘小鼠模型的支气管病变之前会出现免疫复合物血管炎和诱导性支气管相关淋巴组织(iBALT)。
Lab Invest. 2015 Aug;95(8):886-902. doi: 10.1038/labinvest.2015.72. Epub 2015 Jun 1.
4
Protein-based therapies for acute lung injury: targeting neutrophil extracellular traps.针对急性肺损伤的蛋白质类疗法:靶向中性粒细胞胞外诱捕网。
Expert Opin Ther Targets. 2014 Jun;18(6):703-14. doi: 10.1517/14728222.2014.902938. Epub 2014 Mar 26.
5
Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor.尿激酶受体通过补体 C5a 受体介导间充质干细胞的成骨分化和血管钙化。
Stem Cells Dev. 2014 Feb 15;23(4):352-62. doi: 10.1089/scd.2013.0318. Epub 2013 Dec 11.
6
Urokinase receptor counteracts vascular smooth muscle cell functional changes induced by surface topography.尿激酶受体可拮抗表面形貌引起的血管平滑肌细胞功能变化。
Theranostics. 2013 Jul 3;3(7):516-26. doi: 10.7150/thno.4119. Print 2013.
7
Neutrophil recruitment to the lung in both C5a- and CXCL1-induced alveolitis is impaired in vitamin D-binding protein-deficient mice.维生素 D 结合蛋白缺陷小鼠中,C5a 和 CXCL1 诱导的肺泡炎中中性粒细胞向肺的募集受损。
J Immunol. 2013 Jul 15;191(2):848-56. doi: 10.4049/jimmunol.1202941. Epub 2013 Jun 10.
8
Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome.急性肺损伤和急性呼吸窘迫综合征中凝血和纤溶的治疗调节。
Curr Pharm Biotechnol. 2011 Sep;12(9):1481-96. doi: 10.2174/138920111798281171.
9
Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.尿激酶型纤溶酶原激活物与关节炎进展:免疫复合物参与的全身性疾病中的作用。
Arthritis Res Ther. 2010;12(2):R37. doi: 10.1186/ar2946. Epub 2010 Mar 2.
10
Serine proteases, inhibitors and receptors in renal fibrosis.肾纤维化中的丝氨酸蛋白酶、抑制剂和受体。
Thromb Haemost. 2009 Apr;101(4):656-64.